Shaoqing Liu
Zhengzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Mitochondria-Associated Endoplasmic Reticulum Membranes in Cancer: Hubs for Tumor Progression and Therapeutic Vulnerabilities.
Journal: Cell biology international
Published: May 07, 2026
Liver ischemia-reperfusion promotes tumor metastasis via neutrophil-endothelial interactions: targeting ICAM1 to prevent metastatic recurrence.
Journal: Journal of translational medicine
Published: September 02, 2025
DNMT2-m5C-ACLY Axis Promotes Lenvatinib Resistance in Hepatocellular Carcinoma Through Histone Acetylation-Mediated Notch Pathway.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: August 21, 2025
Galectin-4 drives anti-PD-L1/BVZ resistance by regulating metabolic adaptation and tumour-associated neutrophils in hepatocellular carcinoma.
Journal: Gut
Published: July 09, 2025
Coptisine Improves Liver Inflammation in Sepsis by Regulating STAT1/IRF1/GPX4 Signaling-Mediated Kupffer Cells Ferroptosis.
Journal: Phytotherapy research : PTR
Published: May 31, 2025
PLAUR+ Neutrophils Drive Anti-PD-1 Therapy Resistance in Patients with Hepatocellular Carcinoma by Shaping an Immunosuppressive Microenvironment.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 21, 2025
FMO2+ cancer-associated fibroblasts sensitize anti-PD-1 therapy in patients with hepatocellular carcinoma.
Journal: Journal for immunotherapy of cancer
Published: April 14, 2025
Targeting CREB3L2-mediated lipid metabolism overcomes lenvatinib resistance and attenuates the progression of hepatocellular carcinoma.
Journal: Cell death & disease
Published: March 22, 2025
Showing 1-9 of 9
Last Updated: 09/26/2026